IDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug data



IDA2PM is a integrated database for ADMET and adverse effects based on FDA approved drug data, which have been developed as a useful resource for computational analyses and modelling. IDA2PM aims to bridge the gap by providing in a single resource, integrated detailed information on approved drugs such as structures, molecular descriptors, ADMET and adverse effects properties, target and also related bioactivity.
Koska saatavilla2017
JulkaisijaJournal of cheminformatics
Tietojen luontipäivämäärä2016

Siteeraa tätä